Search Results - "Oro, G"

Refine Results
  1. 1

    The validity and reliability of the OneStep smartphone application under various gait conditions in healthy adults with feasibility in clinical practice by Christensen, Jesse C, Stanley, Ethan C, Oro, Evan G, Carlson, Hunter B, Naveh, Yuval Y, Shalita, Rotem, Teitz, Levi S

    “…Abstract Objective Primary purpose of this study was to determine the validity and reliability of the OneStep smartphone application in healthy adults…”
    Get full text
    Journal Article
  2. 2

    Are Two Tests Better Than One? Combining Donor Derived Cell-Free DNA and Gene Expression Profiling for Non-Invasive Surveillance after Heart Transplantation by Purewal, S., Moayedi, Y., Runeckles, K., Fan, C., Gordon, J., Henricksen, E.J., Oro, G., Shudo, Y., Khush, K.K., Teuteberg, J.

    “…Endomyocardial biopsy (EMBx) is the gold standard for acute cellular rejection (ACR) after heart transplantation (HTx). However, the limitations of EMBx has…”
    Get full text
    Journal Article
  3. 3

    Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed by Pittman, Phillip R, Cavicchia, M.A, Kingsbury, J.L, Johnson, N.A, Barrera-Oro, J.G, Schmader, T, Korman, L, Quinn, X, Ranadive, M

    Published in Vaccine (03-09-2014)
    “…Highlights • The anti-PA IgG antibody response and B. anthracis lethal toxin neutralization activity of a cohort delayed as long as 7 years in receiving an…”
    Get full text
    Journal Article
  4. 4

    Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity by Pittman, Phillip R, Fisher, Diana, Quinn, Xiaofei, Schmader, Trevor, Barrera-Oro, Julio G

    Published in Vaccine (17-10-2013)
    “…Highlights • The persistence of anti-PA IgG antibody in humans two years after partial priming doses of anthrax vaccine is described. • Human anti-PA IgG…”
    Get full text
    Journal Article
  5. 5

    Protective Efficacy of a Live Attenuated Vaccine against Argentine Hemorrhagic Fever by Maiztegui, Julio I., McKee, Kelly T., Oro, Julio G. Barrera, Harrison, Lee H., Gibbs, Paul H., Feuillade, Maria R., Enria, Delia A., Briggiler, Ana M., Levis, Silvana C., Ambrosio, Ana M., Halsey, Neal A., Peters, Clarence J.

    Published in The Journal of infectious diseases (01-02-1998)
    “…Argentine hemorrhagic fever (AHF), caused by the arenavirus Junin, is a major public health problem among agricultural workers in Argentina. A prospective,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series by Pittman, Phillip R., Norris, Sarah L., Barrera Oro, Julio G., Bedwell, David, Cannon, Timothy L., McKee, Kelly T.

    Published in Vaccine (24-04-2006)
    “…The antibody profile during and after the six-dose primary vaccination series with anthrax vaccine adsorbed (AVA, Biothrax™) was characterized in 86 human…”
    Get full text
    Journal Article
  8. 8

    Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis by Pittman, Phillip R, Leitman, Susan F, Oro, Julio G Barrera, Norris, Sarah L, Marano, Nina M, Ranadive, Manmohan V, Sink, Bonnie S, McKee, Jr, Kelly T

    “…Recipients of licensed anthrax vaccine (AVA; Biothrax) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We…”
    Get full text
    Journal Article
  9. 9

    Clinical Case Definitions for Argentine Hemorrhagic Fever by Harrison, Lee H., Halsey, Neal A., McKee, Kelly T., Peters, Clarence J., Barrera Oro, Julio G., Briggiler, Ana María, Feuillade, María Rosa, Maiztegui, Julio I.

    Published in Clinical infectious diseases (01-05-1999)
    “…Argentine hemorrhagic fever (AHF) is a potentially lethal infection in Argentina. The case-fatality ratio is >15%, but treatment reduces the mortality rate to…”
    Get full text
    Journal Article
  10. 10

    Junin virus activity in rodents from endemic and nonendemic loci in central Argentina by Mills, J N, Ellis, B A, McKee, Jr, K T, Ksiazek, T G, Oro, J G, Maiztegui, J I, Calderon, G E, Peters, C J, Childs, J E

    “…Small mammals were trapped during a 21-month period at 27 farm sites in 15 localities within and beyond the known endemic area for Argentine hemorrhagic fever…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population by Childs, J E, Glass, G E, Ksiazek, T G, Rossi, C A, Oro, J G, Leduc, J W

    “…We collected 1180 sera and 1363 questionnaires with information on demography, rodent exposure, and history of travel from persons visiting a sexually…”
    Get more information
    Journal Article
  13. 13

    Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus) by Mills, J N, Barrera Oro, J G, Bressler, D S, Childs, J E, Tesh, R B, Smith, J F, Enria, D A, Geisbert, T W, McKee, Jr, K T, Bowen, M D, Peters, C J, Jahrling, P B

    “…Oliveros virus is an agent isolated in cell culture from Bolomys obscurus (Rodentia, Muridae, Sigmodontinae) captured on the central Argentine pampa. Oliveros…”
    Get more information
    Journal Article
  14. 14

    Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques by McKee, Jr, K T, Oro, J G, Kuehne, A I, Spisso, J A, Mahlandt, B G

    Published in Intervirology (01-01-1992)
    “…The protective efficacy of Candid No. 1, a live-attenuated vaccine against Argentine hemorrhagic fever (AHF), was evaluated in non-human primates. Twenty…”
    Get more information
    Journal Article
  15. 15

    Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques by McKee, Jr, K T, Oro, J G, Kuehne, A I, Spisso, J A, Mahlandt, B G

    “…The safety and immunogenicity of Candid #1, a live-attenuated Junin virus vaccine, were evaluated in rhesus macaques. Candid #1 was inoculated subcutaneously…”
    Get more information
    Journal Article
  16. 16

    Kairi virus identified from a febrile horse in Argentina by Calisher, C H, Oro, J G, Lord, R D, Sabattini, M S, Karabatsos, N

    “…A virus isolated from the blood of a febrile horse in Argentina was identified as a strain of Kairi virus. This is the fifth Bunyamwera serogroup virus…”
    Get more information
    Journal Article
  17. 17
  18. 18

    A refined complement-enhanced neutralization test for detecting antibodies to Junin virus by Barrera Oro, J G, McKee, Jr, K T, Spisso, J, Mahlandt, B G, Maiztegui, J I

    Published in Journal of virological methods (01-07-1990)
    “…A refined, complement-enhanced, plaque-reduction neutralization test was developed for measuring neutralizing antibodies against Junin (Argentine hemorrhagic…”
    Get more information
    Journal Article
  19. 19

    Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture by Montamat, E E, De Luca D'Oro, G M, Gallerano, R H, Sosa, R, Blanco, A

    “…Trypanosoma cruzi isolated from 55 chronic chagasic patients were grouped into isozymic strains on the basis of electrophoretic patterns for a set of six…”
    Get more information
    Journal Article
  20. 20

    Venezuelan equine encephalitis virus: horse virulence of P-676 and MF-8 small and minute plaques by Justines, G, Oro, G, Alvarez, O

    “…The P-676 and MF-8 epizootic strains of Venezuelan equine encephalitis (VEE) virus were found to contain a minute plaque (MP), different from the predominant…”
    Get more information
    Journal Article